(Q44679464)
Statements
First clinical experience using a 'pathotropic' injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer (English)
Erlinda M Gordon
Gerardo H Cornelio
Conrado C Lorenzo
John P Levy
Rebecca A Reed
Liqiong Liu
Frederick L Hall